newsfilter
← Latest News
PR Newswire·

Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent

Ivectosol™ being tested to target certain cancers to pursue novel human intratumoral injection and intravenous infusion TORONTO, May 3, 2021 /PRNewswire/ - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE:MVMD) (FRA: 20MP) (OTCQB